MITHRA PHARMACEUTICALS SA NV NPV financial statements, including revenue, expenses, profit, and loss

The total revenue of 0R91 for the last semiannual is 33.12 M EUR, and it's 370.79% higher compared to the previous semiannual. The net income of H2 23 is -123.03 M EUR.